Clinical profile of eprosartan: A different angiotensin II receptor blocker

Cardiovascular and Hematological Agents in Medicinal Chemistry

Volumn 6, Issue 4, 2008, Pages 253-257

  Blankestijn, P J ^a   Rupp, H ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Eprosartan; Hypertension; Renin angiotensin system; Sympathetic nervous system

Indexed keywords

AMLODIPINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN II; ATENOLOL; CANDESARTAN; DIURETIC AGENT; EMBUSARTAN; ENALAPRIL; EPROSARTAN; HYDROCHLOROTHIAZIDE; IRBESARTAN; LOSARTAN; MOXONIDINE; NITRENDIPINE; NORADRENALIN; PLACEBO; TELMISARTAN; VALSARTAN;

ADRENERGIC SYSTEM; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG ACCUMULATION; DRUG EFFICACY; DRUG PENETRATION; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; ESSENTIAL HYPERTENSION; HEART FAILURE; HUMAN; HYPERTENSION; MONOTHERAPY; MORBIDITY; MORTALITY; NONHUMAN; PATHOGENESIS; PREVALENCE; RECOMMENDED DRUG DOSE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; RISK REDUCTION; STROKE; SYSTOLIC HYPERTENSION;

ACRYLATES; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; HUMANS; HYPERTENSION; IMIDAZOLES; KIDNEY DISEASES; RENIN-ANGIOTENSIN SYSTEM; SYMPATHETIC NERVOUS SYSTEM; THIOPHENES;

EID: 54949086759     PISSN: 18715257     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152508785909500     Document Type: Article

References (53)

1. Reid, I.A. Am. J. Physiol., 1992, 262, E763.
2. Matsukawa, T.; Gotoh. E.; Minamisawa, K.; Kihara, M.; Ueda, S.; Shionoiri, H.; Ishii, M. Am. J. Physiol., 1991, 261, R690.
3. Brooks, D.P.; Eliot, H.; Ohlstein, E.H.; Ruffalo, R.R. Am. Heart J., 1999, 138 (3Pt2), 246.
4. Timmermans, P.B. Hypertens. Res., 1999, 22, 147.
5. Robins, G.W.; Scott, L.J. Drugs, 2005, 65, 2355.
6. Muders, F.; Palkovits, M.; Bahner, U.; Kirst, I.; Elsner, D.; Jandeleit-Dahm, K. Pharmacol. Res., 2001, 43, 251.
7. Balt, J.C.; Mathy, M.J.; Pfaffendorf, M.; van Zwieten, P.A. J. Hypertens., 2002, 20(Suppl. 5), S3.
8. Ohlstein, E.H.; Brooks, D.P.; Feuerstein, G.Z.; Ruffolo, R.R. Pharmacology, 1997, 55, 244.
9. Shetty, S.S.; DelGrande, D. J. Pharmacol. Exp. Ther., 2000, 294, 179.
10. Criscione, L.; de Gasparo, M.; Bühlmayer, P.; Whitebread, S.; Ramjoué, H-P.R.; Wood, J. Br. J. Pharmacol., 1993, 110, 761.
11. Napp, A.; Mathy, M.-J.; Balt, J.C.; Pfaffendorf, M.; van Zwieten, A. Eur. J. Pharmacol., 2003, 469, 117.
12. Arosio, E.; De Marchi, S.; Prior, M.; Rigoni, A.; Lechi, A. J. Hypertens., 2005, 23, 1923.
13. Esler, M. J. Hypertens., 2002, 20(Suppl. 5), S13.
14. White, W.B.; Anwar, A.; Mansoor, G.A.; Sica, D.A. Am. J. Hypertens., 2001, 14, 1248.
15. Elliott, W.J. J. Hum. Hypertens., 1999, 13, 413.
16. Sega, R. Blood Pres., 1999, 8, 114.
17. Ruilope, L.; Jäger, B.; Prichard, B. Blood. Pres., 2001, 10, 223.
18. Hedner, T.; Himmelmann, A. On behalf of the Eprosartan Multinational Study Group. J. Hypertens., 1999, 17, 129.
19. Dhakam, Z.; McEniery, C.M.; Yasmin, P.; Cockcroft, J.R.; Brown, M.J.; Wilkinson, I.B. Am. J. Hypertens., 2006, 19, 214.
20. CAFE investigators. Circulation, 2006, 113, 1213.
21. Oparil, S.; Izzo, J. Circulation, 2006, 113, 1162.
22. Carlberg. B.; Samuelsson, O.; Lindholm, L.H. Lancet, 2004, 364, 1684.
23. Lindholm, L.H.; Carlsberg, B.; Samuelsson, O. Lancet, 2005, 366, 1545.
24. Beevers, G. Lancet, 2005, 366, 1510.
25. Derosa, G.; Ragonesi, P.D.; Mugellini, A.; Ciccarelli, L.; Fogari, R. Hypertens. Res., 2004, 27, 457.
26. Mancia, G.; Bousquet, P.; Elghozi, J.L.; Esler, M.; Grassi, G.; Julius, S.; Reid, J.; van Zwieten, P. J. Hypertens., 2007, 25, 909.
27. Krum, H,; Lambert, E.; Windebank, E.; Campbell, D.; Esler, M. Am. J. Physiol., 2005, 290, H1706.
28. Blankestijn, P.J. Nephrol. Dial. Transplant., 2004, 19, 1354.
29. Zoccali, C.; Mallamaci, F.; Parlongo, S.; Cutrupi, S.; Benedetto, A.; Tripepi, G. Cirulation, 2002, 105, 1354.
30. Neumann, J.; Ligtenberg, G.; Klein, I.I.; Koomans, H.A.; Blankestijn, P.J. Kidney Int., 2004, 65, 1568.
31. Koomans, H.A.; Blankestijn, P.J.; Joles, J.A. J. Am. Soc. Nephrol., 2004, 15, 524.
32. Neumann, J.; Ligtenberg, G., Oey, P.L.; Koomans, H.A; Blankestijn, P.J. J. Am. Soc. Nephrol., 2004, 15, 2902.
33. Neumann, J.; Ligtenberg, G.; Klein, I.H.; Boer, P.; Oey, P.L; Koomans, H.A.; Blankestijn, P.J. Hypertension, 2007, 49, 506.
34. Rayner, B.; Jaeger, B.; Verboom, C.N.; Pascoe, M. Cardiovasc. J. South. Afr., 2004, 15, 32.
35. Hollenberg, N.K. Am. J. Hypertens., 2001; 14(7Pt2), 237S.
36. Frank, H.; Schobel, H.-P.; Vitowsky, J.; Schmeider, R.E.; Heusser, K. Kidney Int., 2003, 63, 617.
37. Osei, S.Y.; Price, D.A.; Laffel, L.M., Lansang, M.C.; Hollenberg, N.K.; Hypertension, 2000, 36, 122.
38. O'Rourke, M.F.; Hashimoto, J. J. Am. Coll. Cardiol., 2007, 50, 1.
39. Brooks, D.P.; Ruffalo, R.R. J. Hypertens. Suppl., 1999, 17, S27.
40. Punzi, H.A.; Punzi, C.F. and the Eprosartan Investigation Group. J. Hum. Hypertens., 2004, 18, 655.
41. Argenziano, L.; Trimarco, B. Curr. Med. Res. Opin., 1999, 11, 9.
42. de la Sierra, A.; Munoz, A.; Arcos, E.; Lopez, J.S.; Relats, J. Investigators of the Etapa II Study. Blood Press. Suppl., 2004, 2, 5.
43. Robles, N.R.; Martin-Agueda, B.; Lopez-Munoz F.; Alamo, C. Investigators of the ESTEPP Study. Int. J. Clin. Pract., 2005, 59, 478.
44. Schrader, J.; Luders, S.; Kulschewski, A.; MOSES Study Group. Stroke, 2005, 36, 1218.
45. Larsen, K.; Hornnes, N.; Boysen, G. Stroke, 2006, 37, 1357.
46. Dahlof, B.; Devereux, R.; Kjeldsen, S.E.; Julius, S.; Beevers, G.; de Faire, U.; Fyhrquist, F.; Ibsen, H.; Kristiansson, K.; Lederballe-Pedersen, O.; Lindholm, L.H.; Nieminen, M.S.; Omvik, P.; Oparil, S.; Wedel, H.; LIFE Study Group. Lancet, 2002, 359, 995.
47. Weber, M.A.; Julius, S.; Kjeldsen, S.E.; Brunner, H.R.; Ekman, S. Lancet, 2004, 363, 2032.
48. Schraders, J.; Luders, S.; Kulschewski, A.; Berger, J.; Zidek, W. Stroke, 2003, 34, 1699.
49. Fournier, A.; Messerli, F.; Achard, J.; Fernandez, L. J. Am. Coll. Cardiol., 2004, 43, 1343.
50. Strandberg, T.E. Stroke, 2005, 36, 1225.
51. Luders, S.; Hammersen, F.; Kulschewski, A. Dtsch. Med. Wochenschr., 2006, 131, 2580.
52. Pathak, A.; Hanon, O.; Negre-Pages, L. Fundamen. Clin. Pharmacol., 2007, 21, 199.
53. Shlyakhto, E. Curr. Med. Res. Opin., 2007, 23(suppl. 5), S13.